With less than three months before the clock runs out on telemedicine electronic prescribing flexibilities, Reps. Doris Matsui, D-California, and Earl “Buddy” Carter, R-Georgia, are leading a bipartisan charge to urge the U.S. Drug…
Continue Reading
More than 330 healthcare organizations signed letters this week urging the White House and Congress to extend a telehealth prescribing flexibility that was introduced during the Covid-19 pandemic.
Failure to extend this policy would cause…
Continue Reading
With just four months to go until the scheduled expiration of Drug Enforcement Administration flexibilities on virtual prescribing of controlled substances, a long list of hundreds of healthcare stakeholders is calling on Congress and…
Continue Reading
What You Should Know:
– Over 330 stakeholder organizations have joined forces to call on Congress and the White House to intervene and ensure ongoing access to remote prescribing of controlled substances.
– Led by the…
Continue Reading
In an April 2 letter, a group of over 200 stakeholders urged the Drug Enforcement Administration (DEA) to release a revised proposed rule that would “permit and regulate the prescribing of controlled substances through…
Continue Reading
With current pandemic-era flexibilities for telemedicine set to expire at the end of 2024, several telehealth groups and major health systems are calling on the U.S. Drug Enforcement Administration to work faster in crafting…
Continue Reading
By Anuja Vaidya
March 06, 2024 – The United States Attorney’s Office for the Central District of California has sentenced a former physician to 37 months in federal prison for illegally prescribing medications, including opioid-based drugs,…
Continue Reading
This month, the U.S. Department of Health and Human Services (HHS) and the Substance Abuse and Mental Health Services Administration (SAMHSA) took steps to expand access to opioid use disorder treatment through its new…
Continue Reading
Two bills in U.S. Congress this year are expected to boost e-prescriptions. This article explains the complexities that makes it so hard to implement electronic prescribing for controlled substances (EPCS), summarizes the intended impacts…
Continue Reading
When the Drug Enforcement Administration (DEA) released its proposed rule that would remove some of the Covid-19 telehealth flexibilities for the prescribing of controlled substances, it caused an uproar from telehealth companies and advocates….
Continue Reading
